Inventor · disambiguated record
Mark Behnke
Also filed as: BEHNKE MARK · BEHNKE MARK L
39 granted patents·5 pending applications·681 citations·filing 1994–2019
98Inventor score
Files withINFINITY PHARMACEUTICALS INC12MYCOVIA PHARMACEUTICALS INC8MILLENNIUM PHARM INC5WYETH CORP5BEHNKE MARK L4
Top patents by PatentIndex Score
44 records- 0199US7812164B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2007·Granted Oct 12, 2010·84 cites·2 claims
- 0298US6794516B2Synthesis of clasto-lactacystin β-lactone and analogs thereofMILLENNIUM PHARM INC·Filed 2003·Granted Sep 21, 2004·70 cites·23 claims
- 0398US6294560B1Synthesis of clasto-lactacystin β-lactone and analogs thereofMILLENNIUM PHARM INC·Filed 2000·Granted Sep 25, 2001·75 cites·6 claims
- 0497US6566553B2Synthesis of clasto-lactacystin β-lactone and analogs thereofMILLENNIUM PHARM INC·Filed 2001·Granted May 20, 2003·48 cites·2 claims
- 0596US6133308ASynthesis of clasto-lactacystin beta-lactone and analogs thereofMILLENNIUM PHARM INC·Filed 1998·Granted Oct 17, 2000·78 cites·34 claims
- 0695US10406139B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2018·Granted Sep 10, 2019·8 cites·5 claims
- 0795US6797708B2Inhibitors of cytosolic phospholipase A2WYETH CORP·Filed 2002·Granted Sep 28, 2004·66 cites·47 claims
- 0894US9492435B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Nov 15, 2016·13 cites·15 claims
- 0994US8785635B2Cyclopamine analogsAUSTAD BRIAN·Filed 2008·Granted Jul 22, 2014·16 cites·38 claims
- 1094US8669365B2Cyclopamine analogsAUSTAD BRIAN·Filed 2008·Granted Mar 11, 2014·21 cites·25 claims
- 1194US6849743B2Synthesis of clasto-lactacystin β-lactone and analogs thereofMILLENNIUM PHARM INC·Filed 2003·Granted Feb 1, 2005·71 cites·2 claims
- 1291US6984735B2Process for making an aldehydeWYETH CORP·Filed 2003·Granted Jan 10, 2006·33 cites·14 claims
- 1390US11007181B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2019·Granted May 18, 2021·1 cites·2 claims
- 1490US9951083B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Apr 24, 2018·4 cites·19 claims
- 1589US6635771B2N-benzhydryl indole compoundsWYETH CORP·Filed 2002·Granted Oct 21, 2003·29 cites·8 claims
- 1687US10017494B2Antifungal compound processVIAMET PHARMACEUTICALS INC·Filed 2015·Granted Jul 10, 2018·4 cites·17 claims
- 1787US7947663B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2007·Granted May 24, 2011·6 cites·12 claims
- 1886US7605156B2Methods for the use of inhibitors of cytosolic phospholipase A2WYETH CORP·Filed 2005·Granted Oct 20, 2009·10 cites·34 claims
- 1983US10173998B2Antifungal compound processMYCOVIA PHARMACEUTICALS INC·Filed 2015·Granted Jan 8, 2019·4 cites·16 claims
- 2083US10077250B2Antifungal compound processMYCOVIA PHARMACEUTICALS INC·Filed 2015·Granted Sep 18, 2018·4 cites·4 claims
- 2182US8349814B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2011·Granted Jan 8, 2013·3 cites·17 claims
- 2282US7101875B2Methods for treating arthritic disordersWYETH CORP·Filed 2002·Granted Sep 5, 2006·13 cites·48 claims
- 2381US8629125B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2012·Granted Jan 14, 2014·3 cites·18 claims
- 2479US9981943B2Antifungal compound processVIAMET PHARMACEUTICALS INC·Filed 2015·Granted May 29, 2018·3 cites·6 claims
- 2577US8329675B2Inhibitors of fatty acid amide hydrolaseADAMS JULIAN·Filed 2011·Granted Dec 11, 2012·2 cites·31 claims
- 2675US9108989B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Aug 18, 2015·1 cites·16 claims
- 2775US7906548B2Methods for the use of inhibitors of cytosolic phospholipase A2WYETH LLC·Filed 2009·Granted Mar 15, 2011·2 cites·22 claims
- 2870US7713964B2Methods for treating asthmatic conditionsWYETH LLC·Filed 2002·Granted May 11, 2010·5 cites·48 claims
- 2968US8765735B2Isoxazolines as inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Jul 1, 2014·1 cites·30 claims
- 3062US10428025B2Antifungal compound processMYCOVIA PHARMACEUTICALS INC·Filed 2019·Granted Oct 1, 2019·0 cites·3 claims
- 3162US10421741B2Antifungal compound processMYCOVIA PHARMACEUTICALS INC·Filed 2018·Granted Sep 24, 2019·0 cites·2 claims
- 3262US10407392B2Antifungal compound processMYCOVIA PHARMACEUTICALS INC·Filed 2019·Granted Sep 10, 2019·0 cites·3 claims
- 3357US2015344503A1Inhibitors of fatty acid amide hydrolase, methods of treatment and methods of preparing sameINFINITY PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3453US10392365B2Antifungal compound processMYCOVIA PHARMACEUTICALS INC·Filed 2019·Granted Aug 27, 2019·0 cites·2 claims
- 3553US2015099738A1Isoxazolines as inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3651US10399943B2Antifungal compound processMYCOVIA PHARMACEUTICALS INC·Filed 2015·Granted Sep 3, 2019·0 cites·16 claims
- 3751US2019177298A1Antifungal Compound ProcessMYCOVIA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3849US2015031693A1Pak inhibitors for the treatment of fragile x syndromeAFRAXIS HOLDINGS INC·Filed 2012·Application pending·0 cites
- 3945US8957049B2Inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Feb 17, 2015·0 cites·21 claims
- 4043US10000465B2Antifungal compound processVIAMET PHARMACEUTICALS INC·Filed 2015·Granted Jun 19, 2018·0 cites·2 claims
- 4143US9149465B2Isoxazolines as inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Oct 6, 2015·0 cites·10 claims
- 4241US2015368278A1Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4339US5594008APyrrolidine derivatives inhibitors of leukotriene biosynthesisBOEHRINGER INGELHEIM PHARMA·Filed 1994·Granted Jan 14, 1997·3 cites·9 claims
- 4434US8927551B2Isoxazolines as inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Jan 6, 2015·0 cites·45 claims
Join the waitlist — get patent alerts
Get an alert when Mark Behnke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →